Abstract
The TITAN project aims to improve immunotherapy, targeting the efficiency of methods to obtain genetically engineered T cells. Immunotherapy has achieved great success in clinical trials, but it is currently very expensive in terms of time required for analysis, reagents, and samples. TITAN aims to the continuous sampling of critical quality attributes, in order to quickly recognize deviations from the desired range and take appropriate corrective actions on process parameters for an optimal outcome. To achieve its aims, TITAN is currently developing microfluidic and sensing tools for the accurate and efficient real-time monitoring of the T cells amplification process.
Funding Information
  • “TITAN Nanotecnologie per l’immunoterapia dei tumori” (ARS01_00906, 2014-2020 Azione II-OS 1.b)
  • FESR Programme PON “Ricerca e Innovazione” (ARS01_00906, 2014-2020 Azione II-OS 1.b)